Literature DB >> 7479855

Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts.

A Budillon1, A Cereseto, A Kondrashin, M Nesterova, G Merlo, T Clair, Y S Cho-Chung.   

Abstract

The RII beta regulatory subunit of cAMP-dependent protein kinase (PKA) contains an autophosphorylation site and a nuclear location signal, KKRK. We approached the structure-function analysis of RII beta by using site-directed mutagenesis. Ser114 (the autophosphorylation site) of human RII beta was replaced with Ala (RII beta-P) or Arg264 of KKRK was replaced with Met (RII beta-K). ras-transformed NIH 3T3 (DT) cells were transfected with expression vectors for RII beta, RII beta-P, and RII beta-K, and the effects on PKA isozyme distribution and transformation properties were analyzed. DT cells contained PKA-I and PKA-II isozymes in a 1:2 ratio. Over-expression of wild-type or mutant RII beta resulted in an increase in PKA-II and the elimination of PKA-I. Only wild-type RII beta cells demonstrated inhibition of both anchorage-dependent and -independent growth and phenotypic change. The growth inhibitory effect of RII beta overexpression was not due to suppression of ras expression but was correlated with nuclear accumulation of RII beta. DT cells demonstrated growth inhibition and phenotypic change upon treatment with 8-Cl-cAMP. RII beta-P or RII beta-K cells failed to respond to 8-Cl-cAMP. These data suggest that autophosphorylation and nuclear location signal sequences are integral parts of the growth regulatory mechanism of RII beta.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479855      PMCID: PMC40666          DOI: 10.1073/pnas.92.23.10634

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Isolation of pure and unaltered liver nuclei morphology and biochemical composition.

Authors:  J CHAUVEAU; Y MOULE; C ROUILLER
Journal:  Exp Cell Res       Date:  1956-08       Impact factor: 3.905

2.  Dissociation and reassociation of the phosphorylated and nonphosphorylated forms of adenosine 3':5' -monophosphate-dependent protein kinase from bovine cardiac muscle.

Authors:  R Rangel-Aldao; O M Rosen
Journal:  J Biol Chem       Date:  1976-06-10       Impact factor: 5.157

3.  Comparison of adenosine 3':5'-monophosphate-dependent protein kinases from rabbit skeletal and bovine heart muscle.

Authors:  F Hofmann; J A Beavo; P J Bechtel; E G Krebs
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

4.  The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues.

Authors:  J D Corbin; S L Keely; C R Park
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

5.  Reversible autophosphorylation of a cyclic 3':5'-AMP-dependent protein kinase from bovine cardiac muscle.

Authors:  O M Rosen; J Erlichman
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

6.  Cyclic AMP-dependent protein kinases from normal and SV40-transformed 3T3 cells.

Authors:  A J Gharrett; A M Malkinson; J R Sheppard
Journal:  Nature       Date:  1976-12-16       Impact factor: 49.962

Review 7.  Phosphorylation-dephosphorylation of enzymes.

Authors:  E G Krebs; J A Beavo
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

8.  Purification and properties of rabbit skeletal muscle adenosine 3',5'-monophosphate-dependent protein kinases.

Authors:  E M Reimann; D A Walsh; E G Krebs
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

9.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

10.  Cyclic AMP-dependent protein kinases from Balb 3T3 cells and other 3T3 derived lines.

Authors:  J M Wehner; A M Malkinson; M F Wiser; J R Sheppard
Journal:  J Cell Physiol       Date:  1981-08       Impact factor: 6.384

View more
  6 in total

1.  Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression.

Authors:  Y S Cho; Y G Park; Y N Lee; M K Kim; S Bates; L Tan; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes.

Authors:  Ghada A Soliman; Hugo A Acosta-Jaquez; Diane C Fingar
Journal:  Lipids       Date:  2010-11-02       Impact factor: 1.880

3.  The RIIbeta regulatory subunit of protein kinase A binds to cAMP response element: an alternative cAMP signaling pathway.

Authors:  R K Srivastava; Y N Lee; K Noguchi; Y G Park; M J Ellis; J S Jeong; S N Kim; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

4.  Ala99ser mutation in RI alpha regulatory subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer cell growth.

Authors:  G R Lee; S N Kim; K Noguchi; S D Park; S H Hong; Y S Cho-Chung
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

5.  8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.

Authors:  A Budillon; E Di Gennaro; M Caraglia; D Barbarulo; A Abbruzzese; P Tagliaferri
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

6.  PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser114 phosphorylation.

Authors:  Isabel Weigand; Cristina L Ronchi; Jens T Vanselow; Kerstin Bathon; Kerstin Lenz; Sabine Herterich; Andreas Schlosser; Matthias Kroiss; Martin Fassnacht; Davide Calebiro; Silviu Sbiera
Journal:  Sci Adv       Date:  2021-02-19       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.